Summit Partners Public Asset Management, LLC Exact Sciences Corp Transaction History

Summit Partners Public Asset Management, LLC

$2.79 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$37.9 - $104.44 $3.58 Million - $9.87 Million	-94,540 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$77.66 - $99.74 $6.98 Million - $8.97 Million	-89,918 Reduced 48.75%	94,540 $8.74 Million
Q3 2019 Nov 14, 2019	BUY	$90.37 - $122.49 $8.42 Million - $11.4 Million	93,224 Added 102.18%	184,458 $16.7 Million
Q2 2019 Aug 14, 2019	BUY	$89.51 - $118.04 $1.01 Million - $1.33 Million	11,234 Added 14.04%	91,234 $10.8 Million
Q1 2019 May 15, 2019	SELL	$61.98 - $96.5 $2.09 Million - $3.26 Million	-33,787 Reduced 29.69%	80,000 $6.93 Million
Q4 2018 Feb 14, 2019	SELL	$56.04 - $82.66 $10.1 Million - $14.9 Million	-180,137 Reduced 61.29%	113,787 $7.18 Million
Q3 2018 Nov 14, 2018	BUY	$48.29 - $80.6 $14.2 Million - $23.7 Million	293,924 New	293,924 $23.2 Million

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

Vanguard Group Inc Valley Forge, PA

17.8M
Shares

$1.02 Billion
0.02% of portfolio
Capital World Investors Los Angeles, CA

15.8M
Shares

$912 Million
0.17% of portfolio
Wellington Management Group LLP Boston, MA

14.3M
Shares

$825 Million
0.18% of portfolio
Black Rock Inc. New York, NY

12.1M
Shares

$694 Million
0.01% of portfolio
State Street Corp Boston, MA

6.68M
Shares

$384 Million
0.02% of portfolio

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Partners Public Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Partners Public Asset Management, LLC with notifications on news.

Account